The Medicines Regulator (Infarmed) assured this Thursday that it “complies with the current legislation regarding the Authorization for Exclusive Use” (AUE) of drugs in the case of Portuguese-Brazilian twins treated in Lisbon with a drug worth millions of euros.
According to a report published this Thursday, the General Inspectorate of Medical Activities (IGAS) concluded that access to neuropediatric consultation for Portuguese-Brazilian twins treated at the Santa Maria Hospital with drugs worth millions of euros was illegal, recommending Infarmed – The National Medicines and Health Products Administration follows the process for submitting, assessing and approving requests for AUE in accordance with the AUE provision of the Medicines Regulations.
In a statement, Infarmed assures that it “complied in the case under consideration and will continue to comply with the current legislation in matters of AUE.”
Author: Lusa
Source: CM Jornal
I’m Sandra Hansen, a news website Author and Reporter for 24 News Reporters. I have over 7 years of experience in the journalism field, with an extensive background in politics and political science. My passion is to tell stories that are important to people around the globe and to engage readers with compelling content.